MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.985
-0.265 (-11.78%)
Oct 26, 2026, 12:32 PM EDT - Market open
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or 14.08% compared to the previous year. That makes MacroGenics the 24,021st largest employer in the world and 3,096th in the United States.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$597,754
Profits / Employee
-$49,802
Market Cap
126.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | -48 | -14.08% |
| Dec 31, 2024 | 341 | 2 | 0.59% |
| Dec 31, 2023 | 339 | -18 | -5.04% |
| Dec 31, 2022 | 357 | -70 | -16.39% |
| Dec 31, 2021 | 427 | 57 | 15.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Upstream Bio | 75 |
| Acumen Pharmaceuticals | 61 |
| Protara Therapeutics | 46 |
| Compass Therapeutics | 39 |
| TuHURA Biosciences | 22 |
| Satellos Bioscience | 21 |
MGNX News
- 5 hours ago - MacroGenics announces interim data from LINNET study evaluating lorigerlimab - TheFly
- 5 hours ago - MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer - GlobeNewsWire
- 3 days ago - MacroGenics announces interim data from MGC026 study - TheFly
- 3 days ago - MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN - GlobeNewsWire
- 10 days ago - MacroGenics doses first patient in MGC030 study - TheFly
- 10 days ago - MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors - GlobeNewsWire
- 5 weeks ago - MacroGenics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire